Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cellebrite DI (CLBT) EBIT Margin: 2020-2025

Historic EBIT Margin for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to 15.07%.

  • Cellebrite DI's EBIT Margin fell 313.00% to 15.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 13.47%, marking a year-over-year decrease of 112.00%. This contributed to the annual value of 14.18% for FY2024, which is 396.00% up from last year.
  • Cellebrite DI's EBIT Margin amounted to 15.07% in Q3 2025, which was up 18.39% from 12.73% recorded in Q2 2025.
  • Cellebrite DI's 5-year EBIT Margin high stood at 18.20% for Q3 2024, and its period low was 0.19% during Q1 2023.
  • Moreover, its 3-year median value for EBIT Margin was 13.05% (2024), whereas its average is 12.14%.
  • Per our database at Business Quant, Cellebrite DI's EBIT Margin crashed by 1,218bps in 2021 and then soared by 1,450bps in 2023.
  • Quarterly analysis of 5 years shows Cellebrite DI's EBIT Margin stood at 6.34% in 2021, then spiked by 673bps to 13.07% in 2022, then spiked by 306bps to 16.13% in 2023, then tumbled by 170bps to 14.42% in 2024, then tumbled by 313bps to 15.07% in 2025.
  • Its EBIT Margin was 15.07% in Q3 2025, compared to 12.73% in Q2 2025 and 11.41% in Q1 2025.